CEREVEL (NASDAQ:CERE) INVESTOR ALERT: Cerevel’s $45 Per Share Offer is Being Investigated by BFA Law, Shareholders are Encouraged to Contact the Firm
22 juin 2024 06h04 HE
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law about their rights relating to the upcoming merger.
CEREVEL INVESTOR REMINDER: Think $45 Per Share is Too Low for Cerevel (Nasdaq:CERE)? Contact BFA Law about Continuing Investigation into the Offer
20 juin 2024 07h07 HE
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
CEREVEL STOCK UPDATE: Is $45 Per Share Enough for Cerevel (Nasdaq:CERE)? Contact BFA Law about Ongoing Investigation into the Deal Price
18 juin 2024 06h13 HE
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
CEREVEL STOCK NOTICE: Think $45 Per Share is Too Low for Cerevel (Nasdaq: CERE)? Contact BFA Law about Ongoing Investigation into the Deal Price
15 juin 2024 06h37 HE
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
CEREVEL SHAREHOLDER REMINDER: Is $45 Per Share Enough for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Encourages Investors to Contact the Firm
13 juin 2024 07h35 HE
|
Bleichmar Fonti & Auld
Cerevel Shareholders are encouraged to contact BFA Law firm about their rights relating to the upcoming merger.
CEREVEL ALERT: Is $45 Per Share Too Low for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Urges Shareholders to Contact the Firm About Your Rights
11 juin 2024 06h28 HE
|
Bleichmar Fonti & Auld
NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
CEREVEL NEWS NOTIFICATION: BFA Law Alerts Cerevel (Nasdaq: CERE) Shareholders of Investigation into the $45 Merger Offer, Contact the Firm About Your Rights
08 juin 2024 05h12 HE
|
Bleichmar Fonti & Auld
NEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
CEREVEL INVESTIGATION ALERT: Cerevel (Nasdaq: CERE) Investors are Encouraged to Contact BFA Law about the $45 Merger Offer from AbbVie
05 juin 2024 15h31 HE
|
Bleichmar Fonti & Auld
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation into the $45 Merger Offer
01 juin 2024 05h36 HE
|
Bleichmar Fonti & Auld
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE) and AbbVie, Inc. If...
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: CERE) – Contact BFA Law to Discuss How this Impacts You
28 mai 2024 07h26 HE
|
Bleichmar Fonti & Auld
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between (Nasdaq: CERE) Cerevel Therapeutics Holdings, Inc. and AbbVie, Inc. If...